Incidence of ventilator-associated pneumonia: Egyptian study

被引:8
|
作者
Elkolaly, Reham M. [1 ]
Bahr, Hoda M. [1 ]
El-Shafey, Basem, I [1 ]
Basuoni, Ahmed S. [2 ]
Elber, Eman H. [3 ]
机构
[1] Tanta Univ, Fac Med, Chest Dept, Tanta, Egypt
[2] Tanta Univ, Fac Med, Anaesthia Dept, Tanta, Egypt
[3] Tanta Univ Hosp, Chest Dept, Tanta, Egypt
关键词
hospital acquired pneumonia; intensive care unit; mechanical ventilation; ventilator-associated pneumonia; INTENSIVE-CARE-UNIT; RISK-FACTORS; SUSCEPTIBILITY; ETIOLOGY; ONSET;
D O I
10.4103/ejb.ejb_43_18
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background Despite different ICU admission causes, ventilator-associated pneumonia (VAP) is still a common cause of mortality and morbidity in intubated patients and impedes obvious progression in diagnostic modalities and management of these infections. Aim of study The aim of this study was to estimate VAP incidence in Tanta University Hospitals ICUs. Settings and design This was a crossover observational study. Patients and methods This was a one-year study (April 2015 to March 2016), including patients on invasive ventilation who developed VAP, with evaluation of admission and ventilation causes, isolation of causative organisms, and study of used antibiotics and ventilation modes. Statistical analysis Data were statistically analyzed using the SPSS software for Windows (IBM SPSS Statistics 21.0). Results It is a statistics based study aimed to trace infection incidence in national hospital ICUs. Among 222 admitted patients, only 38.4% fulfilled the criteria of VAP. Admission was because of cardiovascular impairment, cardiac arrest, respiratory failure, or head trauma. The ventilation mode at VAP time was assisted control (75%) and synchronized intermittent mandatory ventilation (25%). The minimum intubation period was 7 days, whereas the maximum period was 37 days. Isolated organisms were Pseudomonas (37.5%), Klebsiella (25%), Staphylococcus (20.8%), and methicillin-resistant Staphylococcus aureus (4.2%). The antibiotics used were amikacin, imipenem, vancomycin, levofloxacin, ceftazidime, and teicoplanin (29, 25, 21, 12.5, 8.3, and 4.2%, respectively). The minimum period of antibiotic used was 5 days, whereas the maximum period was 35 days. The highest incidence of VAP occurred in February, whereas the lowest incidence occurred in July. Conclusion The incidence of VAP is still high and varies according to the intubation cause and period, and the underlying morbidity. More efforts must be made to prevent, diagnose, and manage infection early and properly to reduce patient suffering and to reduce the burden on the serving hospitals.
引用
收藏
页码:258 / 266
页数:9
相关论文
共 50 条
  • [31] Ventilator-associated pneumonia
    Chastre, J
    Fagon, JY
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 165 (07) : 867 - 903
  • [32] Ventilator-associated pneumonia
    Torres, A
    EUROPEAN RESPIRATORY JOURNAL, 2001, 18 (06) : 1079 - 1080
  • [33] Ventilator-associated pneumonia
    Hauser, CJ
    Poole, GV
    CRITICAL CARE MEDICINE, 1996, 24 (05) : 900 - 901
  • [34] Ventilator-associated pneumonia
    Ranzani, Otavio T.
    Niederman, Michael S.
    Torres, Antoni
    INTENSIVE CARE MEDICINE, 2022, 48 (09) : 1222 - 1226
  • [35] Ventilator-Associated Pneumonia
    Li Bassi, Gianluigi
    Ferrer, Miguel
    Daniel Marti, Joan
    Comaru, Talitha
    Torres, Antoni
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 35 (04) : 469 - 481
  • [36] VENTILATOR-ASSOCIATED PNEUMONIA
    KOLLEF, MH
    CHEST, 1994, 106 (02) : 646 - 646
  • [37] Ventilator-associated Pneumonia
    Klapdor, B.
    Ewig, S.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2014, 139 (06) : 251 - 254
  • [38] Ventilator-associated pneumonia
    Morehead, RS
    Pinto, SJ
    ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (13) : 1926 - 1936
  • [39] Ventilator-associated pneumonia
    Bindl, L.
    KLINISCHE PADIATRIE, 2010, 222 : S20 - S20
  • [40] Ventilator-Associated Pneumonia
    Jeon, Kyeongman
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2011, 70 (03) : 191 - 198